PROM1 and colorectal carcinoma: In order to examine the effects of cetuximab on the CSC population of CRC cells treated with chemotherapeutic drugs (e.g. 5-FU), we isolated CSC-like cells from CRC cell lines using different CSC markers, CD133, CD44 and EphB2, independently.